Position in JAZZ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$273,763,844
+$81,915,908 QoQ
Shares Held
1,136,091
+12.0% QoQ
Ownership
1.75%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#16
of 629 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 24%
Shared 0%
None 76%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Derivatives in JAZZ
reported options exposure · as of Mar 31, 2025CallValue
$0
CallShares
0
PutValue
$3,103,750
PutShares
25,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,049,938,280 across 338 Biotechnology names. JAZZ ranks #6 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in JAZZ
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $273,763,844 | 1,136,091 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $191,847,936 | 1,014,800 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $155,574,480 | 915,144 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $127,569,349 | 967,901 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $111,688,113 | 1,052,470 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,103,750 | 25,000 | Put | Defined | 2025-05-15 | |
| 2025-03-31 | $123,347,118 | 993,533 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $72,824,008 | 591,344 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $69,852,395 | 626,985 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $53,355,069 | 499,907 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $68,393,979 | 567,962 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,303,800 | 10,600 | Call | Defined | 2024-02-14 | |
| 2023-12-31 | $57,869,532 | 470,484 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $100,801,396 | 778,750 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $66,903,754 | 539,677 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $73,819,385 | 504,472 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $45,495,587 | 285,579 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $47,458,833 | 356,057 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $46,910,643 | 300,690 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $47,004,709 | 301,951 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $32,410,303 | 254,398 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $38,053,088 | 292,244 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $76,942,986 | 433,140 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $61,273,024 | 372,775 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $59,983,294 | 363,425 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $38,552,198 | 270,371 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $38,932,473 | 352,841 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $3,361,238 | 33,700 | Put | Defined | 2020-05-15 | |
| 2020-03-31 | $29,578,594 | 296,557 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||